Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.26B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$268M |
| 3 |
Baxter International
BAX
|
+$212M |
| 4 |
UnitedHealth
UNH
|
+$185M |
| 5 |
Corteva
CTVA
|
+$169M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
| 2 |
Microsoft
MSFT
|
+$260M |
| 3 |
Meta Platforms (Facebook)
META
|
+$251M |
| 4 |
Salesforce
CRM
|
+$226M |
| 5 |
Match Group
MTCH
|
+$188M |
Sector Composition
| 1 | Technology | 22.84% |
| 2 | Healthcare | 15.09% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Enanta Pharmaceuticals
ENTA
$177M
| $3.66M | ﹤0.01% |
70,475
-1,543
| -2% | -$80K |
|
2052
AMERISAFE
AMSF
$841M
| $3.65M | ﹤0.01% |
78,130
-1,908
| -2% | -$89.2K |
|
2053
Allegiant Air
ALGT
$1.19B
| $3.64M | ﹤0.01% |
49,890
-779
| -2% | -$56.9K |
|
|
PAYA
2054
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $3.63M | ﹤0.01% |
593,790
+66,148
| +13% | +$404K |
|
2055
CoreCivic
CXW
$2.26B
| $3.62M | ﹤0.01% |
409,630
-14,283
| -3% | -$126K |
|
2056
Clearfield
CLFD
$453M
| $3.61M | ﹤0.01% |
34,541
-265
| -0.8% | -$27.7K |
|
2057
Buckle
BKE
$3.04B
| $3.61M | ﹤0.01% |
114,110
-18,468
| -14% | -$585K |
|
2058
Wolverine World Wide
WWW
$2.48B
| $3.61M | ﹤0.01% |
234,684
-7,313
| -3% | -$113K |
|
2059
Heritage Financial
HFWA
$833M
| $3.61M | ﹤0.01% |
136,206
-3,526
| -3% | -$93.3K |
|
|
HSKA
2060
DELISTED
Heska Corp
HSKA
| $3.59M | ﹤0.01% |
49,264
-21,505
| -30% | -$1.57M |
|
2061
Emergent Biosolutions
EBS
$434M
| $3.59M | ﹤0.01% |
170,976
-2,064
| -1% | -$43.3K |
|
|
VRE
2062
Veris Residential
VRE
$1.49B
| $3.59M | ﹤0.01% |
315,370
-39,105
| -11% | -$445K |
|
2063
Regenxbio
RGNX
$465M
| $3.58M | ﹤0.01% |
135,367
-3,988
| -3% | -$105K |
|
|
ACCD
2064
DELISTED
Accolade, Inc. Common Stock
ACCD
| $3.58M | ﹤0.01% |
313,251
+3,813
| +1% | +$43.5K |
|
2065
Mirion Technologies
MIR
$5.24B
| $3.57M | ﹤0.01% |
477,991
-12,156
| -2% | -$90.8K |
|
|
PTRA
2066
DELISTED
Proterra Inc. Common Stock
PTRA
| $3.56M | ﹤0.01% |
714,147
-13,897
| -2% | -$69.2K |
|
2067
Hillman Solutions
HLMN
$1.92B
| $3.56M | ﹤0.01% |
471,644
-9,421
| -2% | -$71K |
|
2068
Lemonade
LMND
$3.88B
| $3.55M | ﹤0.01% |
167,773
+8,243
| +5% | +$175K |
|
2069
Core & Main
CNM
$9.28B
| $3.55M | ﹤0.01% |
156,203
-4,633
| -3% | -$105K |
|
2070
Tompkins Financial
TMP
$1B
| $3.55M | ﹤0.01% |
48,881
-2,156
| -4% | -$157K |
|
2071
Reynolds Consumer Products
REYN
$4.84B
| $3.55M | ﹤0.01% |
136,420
-3,837
| -3% | -$99.8K |
|
2072
Fastly
FSLY
$1.14B
| $3.54M | ﹤0.01% |
386,258
-8,319
| -2% | -$76.2K |
|
2073
Adtran
ADTN
$809M
| $3.53M | ﹤0.01% |
182,718
+28,768
| +19% | +$556K |
|
2074
Fulgent Genetics
FLGT
$670M
| $3.53M | ﹤0.01% |
92,607
-133,345
| -59% | -$5.08M |
|
2075
C4 Therapeutics
CCCC
$189M
| $3.52M | ﹤0.01% |
401,884
-6,175
| -2% | -$54.1K |
|